• Home
  • Canton Biologics
  • Integrated Biosimilar CMC Solutions – from Development to Commercial Manufacturing

Integrated Biosimilar CMC Solutions – from Development to Commercial Manufacturing

Integrated Biosimilar CMC Solutions – from Development to Commercial Manufacturing
Product Description

End‑to‑end biosimilar development from cell line construction to PPQ and commercial batches. The integrated platform enables a fast development timeline, supports global GMP requirements, and offers competitive cost of goods. Includes DS/DP manufacturing, analytical testing, quality support, and technology transfer.

Read more Show less

Canton Biologics

  • Country/Region:
    Hong Kong
  • Founded:
    2016
  • On CPHI since:
    2026
  • Employees:
    250 - 499
Company types
CMO/CDMO
View company profile
Categories
more categories Show less
Specifications
  • CAS Registry Number
    N/A
  • Details
    Full CMC services including cell line development, upstream/downstream process development, analytical development, process characterization, technology transfer, process validation (PPQ), and commercial manufacturing; compliant with NMPA, FDA, and EMA GMP, with EU QP release support.

  • Selling Points
    Fully integrated services from cell line to commercial batch, reducing outsourcing risks and project complexity.

  • Model
    Integrated development model with accelerated timeline
  • Supplied from
    China
  • Measured In
    Container
More specifications Fewer specifications

Canton Biologics

  • Country/Region:
    Hong Kong
  • Founded:
    2016
  • On CPHI since:
    2026
  • Employees:
    250 - 499
Company types
CMO/CDMO
View company profile

More Products from Canton Biologics (5)

  • Biologics Development Solutions for Companion Animal Therapeutics

    Product Biologics Development Solutions for Companion Animal Therapeutics

    Leverages advanced expression technologies, optimised vectors, and flexible bioprocessing platforms to deliver scalable and cost‑efficient solutions tailored to companion animal biologics. Supports from early development to GMP manufacturing, with customisation for veterinary specific requirements.

  • Biomedical and Healthcare Recombinant Protein Solutions

    Product Biomedical and Healthcare Recombinant Protein Solutions

    Combines molecular engineering, host cell optimisation, expression system development, and process optimisation to address complex protein structures. The IgMax® platform enables production of pentameric IgM at high expression levels, with near‑complete pentamer assembly and excellent purity after downstre...
  • Innovative Drug Solutions for Difficult‑to‑Express and Complex Proteins

    Product Innovative Drug Solutions for Difficult‑to‑Express and Complex Proteins

    Integrated development and manufacturing solutions combining molecular engineering, vector optimization, host cell engineering, and customized process development. The platform delivers high titers for mAb production, and DTEasy™ strategies have demonstrated significant yield improvements across various di...
  • Integrated CMC Solutions for Advanced Therapies

    Product Integrated CMC Solutions for Advanced Therapies

    Customised CMC development and manufacturing for a broad range of advanced biologic modalities. Services include process development, analytical characterisation, scale‑up, and GMP manufacturing, tailored to the characteristics and development stage of each modality.

  • Recombinant Antigen and Vaccine Solutions for Livestock & Poultry

    Product Recombinant Antigen and Vaccine Solutions for Livestock & Poultry

    Combines advanced expression technologies with optimised vectors, cell culture processes, and downstream purification for high‑productivity and cost‑efficient manufacturing. Multimerisation and nanoparticle platforms enable the design of defined antigen structures in various multimeric forms, supporting ne...